A four - Year retrospective study of amniocentesis: One centre experience

Hippokratia

Volumn 12, Issue 2, 2008, Pages 113-115

  Daniilidis, A ^a,b   Karydas, H ^a   Zournatzi, V ^a   Tantanasis, T ^a   Giannoulis, C ^a   Tzafettas, J ^a  

^a Intensive Care Unit Hippokratio University Hospital   (Greece)

^b NONE   (Greece)

Author keywords

Amniocentesis; Chromosomal abnormalities; Pregnancy

Indexed keywords

ADULT; AGE DISTRIBUTION; AMNIOCENTESIS; ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; DELIVERY; DOWN SYNDROME; EDWARDS SYNDROME; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GESTATIONAL AGE; HIGH RISK PREGNANCY; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MATERNAL AGE; MEDICAL RECORD REVIEW; NEEDLE; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PREMATURE LABOR; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION;

EID: 41549145767     PISSN: 11084189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Royal College of Obstetricians and Gynaecologists. Amniocentesis and chorionic villus sampling. Guideline No8. London: RCOG Press; 2005, [www.rcog.org.uk]
2. Mann K, Donaghue C, Fox SP, Docherty Z, Ogilvie CM. Strategies for the rapid prenatal diagnosis of chromosome aneuploidy. Eur J Hum Genet 2004; 12: 907-915
3. Alfirevic Z, Sundberg K, Brigham S. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev 2004; CD003252
4. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998; 352: 343-346
5. Antsaklis A, Souka AP, Daskalakis G, Kavalakis Y, Michalas S. Second trimester amnicentesis vs chorionic villus sampling for prenatal diagnosis in multiple gestations. Ultrasound Obstet Gynecol 2002; 20: 476-481
6. Elias S, Simpson JL, Bombard AT. Amniocentesis and fetal blood sampling. In Milunsky A, ed. Genetic disorders and the fetus: diagnosis, prevention, and treatment. 4th ed. Baltimore: Johns Hopkins University Press 1998, pp 53-82
7. Benn PA. Advances in prenatal screening for Down syndrome: II first trimester testing,integrated testing, and future directions. Clin Chim Acta 2002; 324: 1-11
8. Bubb JA, Matthews AL. What's new in prenatal screening and diagnosis? Prim Care 2004 31: 561-82
9. The Canadian Early and Mid-trimester Amniocentesis Trial (CEMAT) Group. Randomised trial to assess safety and fetal outcome of early and midtrimester amniocentesis. Lancet 1998; 24351: 242-247
10. Daniilidis A, Klearhou N, Mauromichali M. Strategies for prenatal diagnosis today. Hippokratia 2006; 10: 22-27
11. Cameron A, Macara L, Brennand J, Milton P. Prenatal diagnostic techniques. In Fetal Medicine for the MRCOG and Beyond. RCOG Press 2002, pp 13-26
12. Tabor A, Philip J, Madsen M, Bang J, Obel EB, Norgaard-Pedersen B. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1986; 7: 1287-1293
13. Klinger K, Landes G, Shook D, et al. Rapid detection of chromosome aneuploidies in uncultured amniocytes by using fluorescence in situ hybridization (FISH). Am J Hum Genet 1992; 51: 55-65
14. Tepperberg J, Pettenati MJ, Rao PN, et al. Prenatal diagnosis using interphase fluorescence in situ hybridization (FISH): 2-year multi-center retrospective study and review of the literature. Prenat Diagn 2001; 21: 293-301
15. Thornton JG, Onwude JL. Prenatal diagnosis. In: Studd J,ed. Progress in Obstetrics and Gynaecology. London, Churchill Livingstone 1993; pp 13-31
16. Eiben B, Trawicki W, Hammans W, Goebel R, Pruggmayer M, Epplen JT. Rapid prenatal diagnosis of aneuploidies in uncultured amniocytes by fluorescence in situ hybridization. Evaluation of >3,000 cases. Fetal Diagn Ther 1999; 14: 193-197
17. Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience. BJOG 2003; 110: 281-286